Rong Sun

Rong Sun

Auto-generated profile, based on publicly available information

Rong Sun

Second Qilu Hospital of Shandong University

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2024 in IEEE Transactions on Artificial Intelligence
Verified
Journal Article
Closed access
YZYongzheng Zhu
Yongzheng Zhu
LRLiangrui Ren
Liangrui Ren
RSRong Sun
Rong Sun
JWJun Wang
Jun Wang
Guoxian YuGuoxian Yu
Guoxian Yu
Herb-target interactions (HTIs) are pivotal for unveiling the underlying pharmacological mechanisms between herbs and biological targets (e.g., proteins and nucleic acids). Unlike typical drugs, each of which is made of one pharmacological compound, the herb is composed of different pharmacological ingredients, while contemporary computational approaches mainly focus on HTIs, neglecting the more refined and informative ingredient-target interactions (ITIs). Furthermore, those methods also disregard the complex associations between herbs and ingredients, which have multi-granular interactions with targets. We propose a multi-instance learning based solution (HTI-MIL) to identify HTIs and the finer ITIs. Particularly, HTI-MIL employs Autoencoder, Convolutional Neural Networks, and Graph Convolution Networks to learn representations of herbs, targets, and ingredients, respectively. Next, it takes herbs as bags and ingredients as instances to model the interplay between herbs and ingredients by multi-instance learning, and aggregates ingredient features toward their hosting herb. After that, it leverages the representation of ingredients and targets to predict ITIs, and fuses the representations of herbs, ingredients and targets to predict HTIs. Experimental results show that HTIMIL outperforms competitive methods by at least 5.2%, 4.8%, and 6.4% in AUROC, AUPRC, and F1-score, respectively. HTIMIL validates on typical herbs and confirms ≥90% of the top 20 candidate targets, and also finds out novel interactions. In addition, the targets identified by HTI-MIL help to dissect the mechanism of herb-induced liver injury, which further validates its effectiveness.

3 January 2025 in IEEE Transactions on Computational Biology and Bioinformatics
Verified
Journal Article
Closed access
LMLongfei Ma
Longfei Ma
CSCong Su
Cong Su
JWJun Wang
Jun Wang
XLXin Li
Xin Li
RSRong Sun
Rong Sun
Guoxian YuGuoxian Yu
Guoxian Yu
The adverse drug-drug interaction (DDI) is a crucial safety concern in drug development. The intricate combinations of traditional Chinese medicine (TCM), while powerful in their therapeutic potentials, also harbor potential risks when incompatibly paired. Some methods have been proposed to infer incompatible herb pairs (IHPs), but most of them focus on revealing and analyzing the adverse reactions of known IHPs, despite that there are still a number of undiscovered IHPs at intervals. This paper introduces a deep attention network (AN-IHP) that effectively exploits diverse types of data for IHPs prediction. AN-IHP designs an attention-aggregation block to learn the ingredient-level features towards herbs and use similarity profiles to represent the efficacy and property. Then it defines commonality and specificity constraints to enhance the representations from different types of features. After that, it makes dynamic representation fusion across herb pairs using a gated attention unit (GAU) and leverages a deep neural network (DNN) to predict IHPs. The experimental results on the collected IHPTCM dataset demonstrate that AN-IHP outperforms competitive methods. AN-IHP provides interpretability for analyzing IHPs at the ingredient level, proves beneficial for wet-lab experiments. It is also capable of predicting DDIs.

14 October 2025
Verified
Preprint
Open access
TZTianyu Zhang
Tianyu Zhang
LCLeilei Chen
Leilei Chen
FJFan Jiang
Fan Jiang
NHNana Huang
Nana Huang
XLXiaolu Li
Xiaolu Li
RSRong Sun
Rong Sun
Drug susceptibility refers to an individual's sensitivity to adverse drug reactions, mainly determined by genetic factors, environmental factors, psychological factors, etc., manifested as the risk of abnormal reactions of the body to specific drugs or metabolites. Differences in drug susceptibility are key factors leading to fluctuations in individualized drug efficacy and toxic side effects. With the development of precision medicine, traditional single research paradigms are no longer able to analyze their complex mechanisms, and there is an urgent need to systematically sort out the evolution path of paradigms and integrate multidimensional technical methods. This article systematically reviews the evolution trajectory of drug susceptibility research paradigms, the progress of multidimensional integration methodologies, and the current challenges faced, in order to achieve a leap from drug susceptibility research results to precision medicine practice.